292 related articles for article (PubMed ID: 26397018)
1. Open access chemical probes for epigenetic targets.
Brown PJ; Müller S
Future Med Chem; 2015; 7(14):1901-17. PubMed ID: 26397018
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of Protein Methyltransferases and Demethylases.
Kaniskan HÜ; Martini ML; Jin J
Chem Rev; 2018 Feb; 118(3):989-1068. PubMed ID: 28338320
[TBL] [Abstract][Full Text] [Related]
3. Chemical probes targeting epigenetic proteins: Applications beyond oncology.
Ackloo S; Brown PJ; Müller S
Epigenetics; 2017 May; 12(5):378-400. PubMed ID: 28080202
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic small molecule modulators of histone and DNA methylation.
Hauser AT; Robaa D; Jung M
Curr Opin Chem Biol; 2018 Aug; 45():73-85. PubMed ID: 29579619
[TBL] [Abstract][Full Text] [Related]
5. Focused Libraries for Epigenetic Drug Discovery: The Importance of Isosteres.
Green AI; Burslem GM
J Med Chem; 2021 Jun; 64(11):7231-7240. PubMed ID: 34042449
[TBL] [Abstract][Full Text] [Related]
6. The SGC beyond structural genomics: redefining the role of 3D structures by coupling genomic stratification with fragment-based discovery.
Bradley AR; Echalier A; Fairhead M; Strain-Damerell C; Brennan P; Bullock AN; Burgess-Brown NA; Carpenter EP; Gileadi O; Marsden BD; Lee WH; Yue W; Bountra C; von Delft F
Essays Biochem; 2017 Nov; 61(5):495-503. PubMed ID: 29118096
[TBL] [Abstract][Full Text] [Related]
7. A new horizon for epigenetic medicine?
Chen S; Shi Y
Cell Res; 2013 Mar; 23(3):326-8. PubMed ID: 22986503
[TBL] [Abstract][Full Text] [Related]
8. Discovery of an MLLT1/3 YEATS Domain Chemical Probe.
Moustakim M; Christott T; Monteiro OP; Bennett J; Giroud C; Ward J; Rogers CM; Smith P; Panagakou I; Díaz-Sáez L; Felce SL; Gamble V; Gileadi C; Halidi N; Heidenreich D; Chaikuad A; Knapp S; Huber KVM; Farnie G; Heer J; Manevski N; Poda G; Al-Awar R; Dixon DJ; Brennan PE; Fedorov O
Angew Chem Int Ed Engl; 2018 Dec; 57(50):16302-16307. PubMed ID: 30288907
[TBL] [Abstract][Full Text] [Related]
9. Successful strategies in the discovery of small-molecule epigenetic modulators with anticancer potential.
Bayo J; Dalvi MP; Martinez ED
Future Med Chem; 2015; 7(16):2243-61. PubMed ID: 26510529
[TBL] [Abstract][Full Text] [Related]
10. Chemical Control System of Epigenetics.
Vaijayanthi T; Pandian GN; Sugiyama H
Chem Rec; 2018 Dec; 18(12):1833-1853. PubMed ID: 30378269
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress in Histone Demethylase Inhibitors.
McAllister TE; England KS; Hopkinson RJ; Brennan PE; Kawamura A; Schofield CJ
J Med Chem; 2016 Feb; 59(4):1308-29. PubMed ID: 26710088
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic targets and drug discovery Part 2: Histone demethylation and DNA methylation.
Liu K; Liu Y; Lau JL; Min J
Pharmacol Ther; 2015 Jul; 151():121-40. PubMed ID: 25857453
[TBL] [Abstract][Full Text] [Related]
13. An Overview on Small Molecule Inhibitors of BRD4.
Huang W; Zheng X; Yang Y; Wang X; Shen Z
Mini Rev Med Chem; 2016; 16(17):1403-1414. PubMed ID: 27290915
[TBL] [Abstract][Full Text] [Related]
14. Host Methyltransferases and Demethylases: Potential New Epigenetic Targets for HIV Cure Strategies and Beyond.
Boehm D; Ott M
AIDS Res Hum Retroviruses; 2017 Nov; 33(S1):S8-S22. PubMed ID: 29140109
[TBL] [Abstract][Full Text] [Related]
15. Challenges in profiling and lead optimization of drug discovery for methyltransferases.
Horiuchi KY
Drug Discov Today Technol; 2015 Nov; 18():62-8. PubMed ID: 26723894
[TBL] [Abstract][Full Text] [Related]
16. Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAs.
Gelato KA; Adler D; Ocker M; Haendler B
Expert Opin Ther Targets; 2016 Jul; 20(7):783-99. PubMed ID: 26799480
[TBL] [Abstract][Full Text] [Related]
17. Small-molecule ligands of methyl-lysine binding proteins.
Herold JM; Wigle TJ; Norris JL; Lam R; Korboukh VK; Gao C; Ingerman LA; Kireev DB; Senisterra G; Vedadi M; Tripathy A; Brown PJ; Arrowsmith CH; Jin J; Janzen WP; Frye SV
J Med Chem; 2011 Apr; 54(7):2504-11. PubMed ID: 21417280
[TBL] [Abstract][Full Text] [Related]
18. Targeting epigenetic reader domains by chemical biology.
Cipriano A; Sbardella G; Ciulli A
Curr Opin Chem Biol; 2020 Aug; 57():82-94. PubMed ID: 32739717
[TBL] [Abstract][Full Text] [Related]
19. Straightforward hit identification approach in fragment-based discovery of bromodomain-containing protein 4 (BRD4) inhibitors.
Borysko P; Moroz YS; Vasylchenko OV; Hurmach VV; Starodubtseva A; Stefanishena N; Nesteruk K; Zozulya S; Kondratov IS; Grygorenko OO
Bioorg Med Chem; 2018 Jul; 26(12):3399-3405. PubMed ID: 29764756
[TBL] [Abstract][Full Text] [Related]
20. Towards the chemoinformatic-based identification of DNA methyltransferase inhibitors: 2D- and 3D-similarity profile of screening libraries.
Yoo J; Medina-Franco JL
Curr Comput Aided Drug Des; 2012 Dec; 8(4):317-29. PubMed ID: 22734709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
